WithdrawnNCT02511613
Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
PHASE2 · 0 planned enrolment
- Countries listed
- 1
- Registry update
- April 27, 2017
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE2 · 0 planned enrolment
PHASE3 · 230 planned enrolment